SCHEMBL7058183

SCHEMBL7058183

CC(C)C1ON=NC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4469647 0.67
SCHEMBL10719706 0.62
SCHEMBL34463727 0.62
SCHEMBL27458276 0.60
SCHEMBL30967327 0.60
SCHEMBL7639194 0.60 LMNA (0.31)
SCHEMBL34463720 0.59
SCHEMBL1605155 0.59 RAB9A (0.40)
SCHEMBL13223451 0.54
SCHEMBL17774455 0.52 SMN1; SMN2 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-121895248-A New pymetrozine intermediate and preparation method thereof 锦州怡嘉科技有限公司 2026-04-21 CN disclosed
US-10792266-B2 Fatty acid analogs and their use in the treatment of conditions related to metabolic syndrome Epitracker, Inc. (US) 2020-10-06 US disclosed
US-20190117607-A1 FATTY ACID ANALOGS AND THEIR USE IN THE TREATMENT OF CONDITIONS RELATED TO METABOLIC SYNDROME Epitracker, Inc. 2019-04-25 US disclosed
EP-1018509-B1 A process for preparing 4-amino-1,2,4-triazolin-5-ones BAYER AG (US) 2003-05-14 EP disclosed
EP-1018509-A1 A process for preparing 4-amino-1,2,4-triazolin-5-ones Bayer Corporation (US) 2000-07-12 EP disclosed
US-5912354-A REACTING AN OXADIAZOLINONE WITH HYDRAZINE HYDRATE IN THE ABSENCE OF A SOLVENT. BAYER CORPORATION (US) 1999-06-15 US disclosed